The spatial omics market size has grown rapidly in recent years. It will grow from $0.33 billion in 2025 to $0.37 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to growth in genomics research funding, expansion of academic life sciences research, advancements in molecular imaging technologies, increasing availability of omics consumables, rising focus on disease biology research.
The spatial omics market size is expected to see rapid growth in the next few years. It will grow to $0.54 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing adoption in drug discovery workflows, rising investments in precision medicine research, expansion of AI-driven biological data analysis, growing demand for spatially resolved biomarkers, increasing pharmaceutical R&D spending. Major trends in the forecast period include increasing adoption of spatial transcriptomics platforms, rising integration of multi-omics data analysis, growing use of high-resolution imaging systems, expansion of advanced data visualization tools, enhanced focus on tissue-level molecular mapping.
The increasing prevalence of genetic disorders is set to drive the growth of the spatial omics market. Genetic illnesses are conditions resulting from abnormalities in an individual's DNA inherited from one or both parents. The rise in genetic diseases is attributed to heightened awareness, improved diagnostic methods, lifestyle shifts, and environmental factors contributing to genetic mutations. Spatial omics technologies offer a potent approach to studying genetic disorders by providing detailed spatial maps of molecular and genetic characteristics within tissues. For instance, in February 2023, the World Health Organization (WHO) reported that congenital diseases caused approximately 240,000 infant deaths globally within the first 28 days of birth annually. Additionally, the Centers for Disease Control and Prevention (CDC) noted that about 6,000 babies are born with Down syndrome in the United States each year, equating to approximately 1 in every 700 births. Consequently, the increasing incidence of genetic diseases is propelling the spatial omics market's expansion.
Major companies in the spatial omics market are focusing on developing end-to-end spatial transcriptomics platforms to enable precise mapping of gene expression within tissue context and deliver deeper biological insights. End-to-end spatial transcriptomics platforms are integrated systems that streamline the entire workflow - from sample preparation to data analysis - allowing researchers to capture, visualize, and interpret gene expression across tissues efficiently. For instance, in February 2025, Illumina Inc., a US-based biotechnology company, launched spatial transcriptomics technology aimed at transforming tissue analysis and cellular mapping. The technology provides unbiased whole-transcriptome profiling at single-cell resolution with high sensitivity, enabling detailed mapping of complex tissues. It features a capture area nine times larger and four times higher in resolution than previous methods, allowing analysis of millions of cells per experiment and identification of rare cell types. Integrated with Illumina’s NextSeq and NovaSeq sequencers, it is paired with the Illumina Connected Multiomics (ICM) platform, offering advanced multiomic visualization and analysis tools for comprehensive spatial data exploration.
In May 2024, Bruker Corporation, a US-based manufacturer of scientific equipment for materials and molecular biology research, acquired NanoString Technologies Inc.'s business for approximately $392.6 million in cash. This acquisition aims to broaden Bruker's spatial biology portfolio by incorporating gene expression profiling and spatial transcriptomics solutions and products. NanoString Technologies Inc. is a US-based company specializing in molecular diagnostic products and life science tools for translational research.
Major companies operating in the spatial omics market are Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Luminex Corporation, Takara Bio Inc., Oxford Nanopore Technologies, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., CrestOptics, Indica Labs Inc., Resolve Biosciences GmbH, Pixelgen Technologies, Ionpath Inc., RareCyte Inc., S2 Genomics Inc., Vizgen Inc., BioSpyder Technologies, Ultivue Inc.
North America was the largest region in the Spatial OMICS market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spatial omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spatial omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the spatial omics market by increasing costs of imported instruments, imaging systems, reagents, mass spectrometers, and high-performance computing hardware used across research workflows. Academic institutions and pharmaceutical companies in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher costs in consumables sourcing. These tariffs are elevating research costs and slowing procurement cycles. However, they are also supporting regional instrument manufacturing, localized reagent production, and collaborative innovation within domestic life sciences ecosystems.
The spatial omics market research report is one of a series of new reports that provides spatial omics market statistics, including spatial omics industry global market size, regional shares, competitors with a spatial omics market share, detailed spatial omics market segments, market trends and opportunities, and any further data you may need to thrive in the spatial omics industry. This spatial omics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Spatial omics is a multidisciplinary domain that combines spatial analysis techniques with omics technologies, enabling the visualization and analysis of biomolecules within their spatial context in tissues. This field serves as a potent tool by merging spatial and molecular data to offer a comprehensive understanding of the organization and functionality of biological systems.
The primary products in the spatial omics market include instruments, consumables, and software. Spatial transcriptomics, for instance, is a technology enabling scientists to examine gene expression patterns within tissue or cells, providing spatial insights into gene activity. Various sample types, such as formalin-fixed paraffin-embedded (FFPE) and fresh frozen samples, are utilized, with workflows encompassing sample preparation, instrumental analysis, and data analysis. Technologies such as spatial transcriptomics, spatial genomics, and spatial proteomics find application across end-users such as academic and translational research institutes, as well as pharmaceutical and biotechnology companies.
The spatial omics market includes revenues earned by entities by providing services such as spatial epigenomics, single-cell spatial analysis, spatial lipidomics and metabolomics, and multi-omics integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial omics market consists of sales of spatial omics instrumentation, imaging systems, and imaging mass spectrometry. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The spatial omics market size is expected to see rapid growth in the next few years. It will grow to $0.54 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing adoption in drug discovery workflows, rising investments in precision medicine research, expansion of AI-driven biological data analysis, growing demand for spatially resolved biomarkers, increasing pharmaceutical R&D spending. Major trends in the forecast period include increasing adoption of spatial transcriptomics platforms, rising integration of multi-omics data analysis, growing use of high-resolution imaging systems, expansion of advanced data visualization tools, enhanced focus on tissue-level molecular mapping.
The increasing prevalence of genetic disorders is set to drive the growth of the spatial omics market. Genetic illnesses are conditions resulting from abnormalities in an individual's DNA inherited from one or both parents. The rise in genetic diseases is attributed to heightened awareness, improved diagnostic methods, lifestyle shifts, and environmental factors contributing to genetic mutations. Spatial omics technologies offer a potent approach to studying genetic disorders by providing detailed spatial maps of molecular and genetic characteristics within tissues. For instance, in February 2023, the World Health Organization (WHO) reported that congenital diseases caused approximately 240,000 infant deaths globally within the first 28 days of birth annually. Additionally, the Centers for Disease Control and Prevention (CDC) noted that about 6,000 babies are born with Down syndrome in the United States each year, equating to approximately 1 in every 700 births. Consequently, the increasing incidence of genetic diseases is propelling the spatial omics market's expansion.
Major companies in the spatial omics market are focusing on developing end-to-end spatial transcriptomics platforms to enable precise mapping of gene expression within tissue context and deliver deeper biological insights. End-to-end spatial transcriptomics platforms are integrated systems that streamline the entire workflow - from sample preparation to data analysis - allowing researchers to capture, visualize, and interpret gene expression across tissues efficiently. For instance, in February 2025, Illumina Inc., a US-based biotechnology company, launched spatial transcriptomics technology aimed at transforming tissue analysis and cellular mapping. The technology provides unbiased whole-transcriptome profiling at single-cell resolution with high sensitivity, enabling detailed mapping of complex tissues. It features a capture area nine times larger and four times higher in resolution than previous methods, allowing analysis of millions of cells per experiment and identification of rare cell types. Integrated with Illumina’s NextSeq and NovaSeq sequencers, it is paired with the Illumina Connected Multiomics (ICM) platform, offering advanced multiomic visualization and analysis tools for comprehensive spatial data exploration.
In May 2024, Bruker Corporation, a US-based manufacturer of scientific equipment for materials and molecular biology research, acquired NanoString Technologies Inc.'s business for approximately $392.6 million in cash. This acquisition aims to broaden Bruker's spatial biology portfolio by incorporating gene expression profiling and spatial transcriptomics solutions and products. NanoString Technologies Inc. is a US-based company specializing in molecular diagnostic products and life science tools for translational research.
Major companies operating in the spatial omics market are Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Luminex Corporation, Takara Bio Inc., Oxford Nanopore Technologies, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., CrestOptics, Indica Labs Inc., Resolve Biosciences GmbH, Pixelgen Technologies, Ionpath Inc., RareCyte Inc., S2 Genomics Inc., Vizgen Inc., BioSpyder Technologies, Ultivue Inc.
North America was the largest region in the Spatial OMICS market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spatial omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spatial omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the spatial omics market by increasing costs of imported instruments, imaging systems, reagents, mass spectrometers, and high-performance computing hardware used across research workflows. Academic institutions and pharmaceutical companies in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher costs in consumables sourcing. These tariffs are elevating research costs and slowing procurement cycles. However, they are also supporting regional instrument manufacturing, localized reagent production, and collaborative innovation within domestic life sciences ecosystems.
The spatial omics market research report is one of a series of new reports that provides spatial omics market statistics, including spatial omics industry global market size, regional shares, competitors with a spatial omics market share, detailed spatial omics market segments, market trends and opportunities, and any further data you may need to thrive in the spatial omics industry. This spatial omics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Spatial omics is a multidisciplinary domain that combines spatial analysis techniques with omics technologies, enabling the visualization and analysis of biomolecules within their spatial context in tissues. This field serves as a potent tool by merging spatial and molecular data to offer a comprehensive understanding of the organization and functionality of biological systems.
The primary products in the spatial omics market include instruments, consumables, and software. Spatial transcriptomics, for instance, is a technology enabling scientists to examine gene expression patterns within tissue or cells, providing spatial insights into gene activity. Various sample types, such as formalin-fixed paraffin-embedded (FFPE) and fresh frozen samples, are utilized, with workflows encompassing sample preparation, instrumental analysis, and data analysis. Technologies such as spatial transcriptomics, spatial genomics, and spatial proteomics find application across end-users such as academic and translational research institutes, as well as pharmaceutical and biotechnology companies.
The spatial omics market includes revenues earned by entities by providing services such as spatial epigenomics, single-cell spatial analysis, spatial lipidomics and metabolomics, and multi-omics integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The spatial omics market consists of sales of spatial omics instrumentation, imaging systems, and imaging mass spectrometry. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Spatial omics Market Characteristics
3. Spatial omics Market Supply Chain Analysis
4. Global Spatial omics Market Trends and Strategies
5. Spatial omics Market Analysis of End Use Industries
7. Global Spatial omics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Spatial omics Total Addressable Market (TAM) Analysis for the Market
9. Spatial omics Market Segmentation
10. Spatial omics Market Regional and Country Analysis
11. Asia-Pacific Spatial omics Market
12. China Spatial omics Market
13. India Spatial omics Market
14. Japan Spatial omics Market
15. Australia Spatial omics Market
16. Indonesia Spatial omics Market
17. South Korea Spatial omics Market
18. Taiwan Spatial omics Market
19. South East Asia Spatial omics Market
20. Western Europe Spatial omics Market
21. UK Spatial omics Market
22. Germany Spatial omics Market
23. France Spatial omics Market
24. Italy Spatial omics Market
25. Spain Spatial omics Market
26. Eastern Europe Spatial omics Market
27. Russia Spatial omics Market
28. North America Spatial omics Market
29. USA Spatial omics Market
30. Canada Spatial omics Market
31. South America Spatial omics Market
32. Brazil Spatial omics Market
33. Middle East Spatial omics Market
34. Africa Spatial omics Market
36. Spatial omics Market Competitive Landscape and Company Profiles
37. Spatial omics Market Other Major and Innovative Companies
40. Spatial omics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Spatial omics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses spatial omics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for spatial omics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spatial omics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Consumables; Software2) By Sample Type: Formalin-Fixed Paraffin-Embedded (FFPE); Fresh Frozen
3) By Workflow: Sample Preparation; Instrumental Analysis; Data Analysis
4) By Technology: Spatial Transcriptomics; Spatial Genomics; Spatial Proteomics
5) By End-Use: Academic And Translational Research Institutes; Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Instruments: Spatial Transcriptomics Instruments; Imaging Systems; Mass Spectrometers2) By Consumables: Reagents; Kits; Sample Preparation Materials
3) By Software: Data Analysis Software; Visualization Tools; Integration Platforms
Companies Mentioned: Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bruker Corporation; QIAGEN N.V.; 10x Genomics Inc.; Luminex Corporation; Takara Bio Inc.; Oxford Nanopore Technologies; NanoString Technologies Inc.; Standard BioTools Inc.; Akoya Biosciences Inc.; CrestOptics; Indica Labs Inc.; Resolve Biosciences GmbH; Pixelgen Technologies; Ionpath Inc.; RareCyte Inc.; S2 Genomics Inc.; Vizgen Inc.; BioSpyder Technologies; Ultivue Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Spatial omics market report include:- Agilent Technologies Inc.
- PerkinElmer Inc.
- Illumina Inc.
- Bruker Corporation
- QIAGEN N.V.
- 10x Genomics Inc.
- Luminex Corporation
- Takara Bio Inc.
- Oxford Nanopore Technologies
- NanoString Technologies Inc.
- Standard BioTools Inc.
- Akoya Biosciences Inc.
- CrestOptics
- Indica Labs Inc.
- Resolve Biosciences GmbH
- Pixelgen Technologies
- Ionpath Inc.
- RareCyte Inc.
- S2 Genomics Inc.
- Vizgen Inc.
- BioSpyder Technologies
- Ultivue Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.37 Billion |
| Forecasted Market Value ( USD | $ 0.54 Billion |
| Compound Annual Growth Rate | 10.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
